CAS: 814-75-5; 3-Bromobutan-2-One

该化合物是属于卤化氯酮类的有机化合物,其特点是四碳链,在第二碳处有一个氯酮功能组(C=O),第三碳处有一个溴原子.该化合物一般没有颜色,可粉色黄色,具有特殊的气味.它溶于乙醇和乙醚等有机溶剂,但因其水分缺乏碳链,在水中溶解性有限.3-Bromo-2-butanone以其再活动性为著称,特别是在核脑细胞替代反应中,在这种反应中,溴原子可被各种核素替代物取代.它通常用作有机合成的中间体,特别是在制药和农用化学品方面.在处理该化合物时,应当采取安全防范措施,因为它可能对健康造成危害,包括对皮肤和呼吸系统造成刺激.建议远离光部的冷干地储存,以保持其稳定性.

结构式图片

相似化合物

2648-71-7 19967-55-6 5798-80-1

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

2-acetoxy-2-butene butanone acetic acid 2,3-dimethyl-2-nitro-oxirane 3-(1'-pyrrolidinyl)-2-butanone 3-cyclohexylidene-butan-2-one 3-((4-methoxyphenyl)amino)butan-2-one 4,5-Dimethylthiazole

合成工艺路线路线简述

    丁酮置于hexabromocyclopenta-1,3-Diene体系中,用 乙腈 作为反应溶剂,化学反应 17.5H,以82%的收率获得产物3-溴-2-丁酮
    参考文献:新型溴化剂.六溴环戊二烯:活化饱和位点的溴化
    标题:新型溴化剂.六溴环戊二烯:活化饱和位点的溴化
    摘要:六溴环戊二烯(hbc)容易溴化α-酮和苄基位点,显然是通过溴离子转移.
    DOI:10.1016/s0040-4039(01)81387-3

    海关参考信息

    专利信息


    专利号:US-2010222601-A1
    优先权日:2006-12-12
    标题 :Synthesis of cyclopentadiene derivatives
    发明人:TAHIRI OUARDIA; JONES ROBERT L; SCHIENDORFER MICHAEL; CHEVALIER REYNALD
    权利人:BASELL POLYOLEFINE GMBH
    摘要:A process for preparing cyclopentadiene derivatives having formula (I) n n n n n n n n n n Wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 equal to or different from each other, are hydrogen atoms or hydrocarbon groups comprising the steps of reacting a substituted or unsubstituted indanon with a base and then with a substituted or unsubstituted haloaceton and treating the obtained product with the Lawesson's reagent.

    专利号:US-10807941-B2
    优先权日:2016-06-03
    标题:Process for the preparation of polysantol-type compounds
    发明人:KNOPFF OLIVER
    权利人:FIRMENICH & CIE
    摘要:The present invention relates to the field of organic synthesis and more specifically it concerns a novel compound of formula (I). The invention additionally relates to a process for preparing a compound of formula (III) using the compound of formula (I) as an intermediate, wherein the process involves elimination of the R3(X)nC(â•?O)O functional group of the compound of formula (I).

    专利号:US-6586453-B2
    优先权日:2000-04-03
    标 题:Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1
    发明人:DHANOA DALE S; RYAN DECLAN E; DECKMAN INGRID; SAPIENZA ANTHONY
    权利人:DIMENSIONAL PHARM INC
    摘要:The present invention relates to the use of aminothiazole derivatives of Formula I of as inhibitors of PAI-1, and to novel classes of aminothiazole derivatives, their synthesis and their use as inhibitors of PAI-1. It has been discovered that compounds of Formula I:or a solvate, hydrate or a pharmaceutically acceptable salt thereof, whereinY, Ar1, Ar2, R1, R2, Z, m and n are described in the specification, inhibit plasminogen activator inhibitor-1 (PAI-1). These compounds can be used in the prophylaxis or for the treatment of thrombosis, angina pectoris, cerebral infarction, myocardial infarction, pulmonary infarction, intra-atrial thrombus in atrial fibrillation, deep venous thrombus, disseminated intravascular coagulation syndrome, diabetic complications, restenosis and stroke.

    专利号:US-4246173-A
    优先权日:1978-04-24
    标题 :Process for preparing tetraselenofulvalenes, and conductive salts obtained therefrom
    发明人:COWAN DWAINE O; BLOCH AARON N; BECHGAARD KLAUS
    权利人:UNIV JOHNS HOPKINS
    摘要:A multistep process for preparing tetraselenofulvalenes involving the synthesis of 1,3-diselenole-2-selones and -2-thiones from diselenocarbamates and α-haloketones followed by coupling of the selone or thione using a dechalkogenizing reagent. New highly conductive salts obtained by coupling certain tetraselenofulvalenes with acceptor compounds are also disclosed.

    专利号:US-8987195-B2
    优先权日:2012-08-08
    标 题:HCV NS3 protease inhibitors
    发明人:BARA THOMAS; BHAT SATHESH; BISWAS DIPSHIKHA; BROCKUNIER LINDA; BURNETT DUANE A; CHACKALAMANNIL SAMUEL; CHELLIAH MARIAPPAN V; CHEN AUSTIN; CLASBY MARTIN; COLANDREA VINCE J; GUO ZHUYAN; HAN YONGXIN; JAYNE CHARLES; JOSIEN HUBERT; MARCANTONIO KAREN; MIAO SHOUWU; NEELAMKAVIL SANTHOSH; PINTO PATRICK; RAJAGOPALAN MURALI; SHAH UNMESH; VELAZQUEZ FRANCISCO; VENKATRAMAN SRIKANTH; XIA YAN
    权利人:MERCK SHARP & DOHME; MERCK CANADA INC
    摘要:The present invention relates to hepatitis C virus (HCV) NS3 protease inhibitors containing a spirocyclic moeity, uses of such compounds, and synthesis of such compounds.

    专利号:US-7772246-B2
    优先权日:2007-08-01
    标题:Pyrazole compounds as RAF inhibitors
    发明人:CUI JINGRONG JEAN; DEAL JUDITH GAIL; GU DANLIN; GUO CHUANGXING; JOHNSON MARY CATHERINE; KANIA ROBERT STEVEN; KEPHART SUSAN ELIZABETH; LINTON MARIA ANGELICA; MCALPINE INDRAWAN JAMES; PAIRISH MASON ALAN; PALMER CYNTHIA LOUISE
    权利人:PFIZER
    摘要:The present invention is directed to compounds of Formula (I), n nand to pharmaceutically acceptable salts thereof, their synthesis, and their use as Raf inhibitors.
    上海凌凯医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.linkchem.cn
    企业联系电话:021-58950110;13124863828👤
    📞上海凌凯医药科技有限公司 ⚠️参考联系方式
    联系人:张经理
    电话:021-58950110;13124863828
    手机:13124863828
    传真:021- 2096 2272
    邮箱:sales@linkchem.cn
    通信地址: 上海市浦东新区国际医学园区康新公路3399弄5号楼
    邮编: 201204
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市浦东新区国际医学园区康新公路3399弄5号楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Yoshida, H., Science of Synthesis Knowledge Updates, (2022) 3, 9.
    摘要:Joule, J. A., Science of Synthesis Knowledge Updates, (2010) 2, 55.
    摘要:National Technical Information Service., OTS0540938
    摘要:Liu, G.; Feng, J., Science of Synthesis: DNA-Encoded Libraries, (2024) nan, 325.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知